-
-
-
-
-
-
-
OncoGenex Pharmaceuticals, Inc. Announces Phase 2 Apatorsen Data for Two Clinical Trials Presented at the American Society of Clinical Oncology (ASCO) 2017 Genitourinary Cancers Symposium
-
-
-
-
-
-
-
After-Hours Stock Movers 01/20: (ECYT) (XLNX) (FEYE) Higher; (OGXI) (SLM) (SRPT) Lower (more...)
-
-
-
-
-
-
-
Pre-Open Stock Movers 8/7: (SAAS) (MCP) (SSYS) (CTRP) Higher; (NSPH) (THOR) (CSOD) Lower (more...)
-
-
-
1,158,058 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

